Treatment options for small cell lung cancer - do we have more choice?

M Puglisi; S Dolly; A Faria; J S Myerson; S Popat; M E R O'Brien

doi:10.1038/sj.bjc.6605527

Treatment options for small cell lung cancer - do we have more choice?

Br J Cancer. 2010 Feb 16;102(4):629-38. doi: 10.1038/sj.bjc.6605527. Epub 2010 Jan 26.

Authors

M Puglisi¹, S Dolly, A Faria, J S Myerson, S Popat, M E R O'Brien

Affiliation

¹ Department of Medicine, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.

Abstract

Small cell lung cancer (SCLC) is a significant health problem worldwide because of its high propensity for relapse. This review discusses existing and future therapies for the treatment of SCLC.

Publication types

Evaluation Study
Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Antineoplastic Agents / chemical synthesis
Antineoplastic Agents / therapeutic use
Antineoplastic Protocols
Biomedical Research / trends
Choice Behavior
Humans
Lung Neoplasms / diagnosis
Lung Neoplasms / pathology
Lung Neoplasms / therapy*
Neoplasm Staging / methods
Prognosis
Small Cell Lung Carcinoma / diagnosis
Small Cell Lung Carcinoma / pathology
Small Cell Lung Carcinoma / therapy*

Substances

Antineoplastic Agents